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Abstract
Background: The most severe complication after the removal of mandibular third molars is injury
to the inferior alveolar nerve or the lingual nerve. These complications are rather uncommon (0.4%
to 8.4%) and most of them are transient. However, some of them persist for longer than 6 months,
which can leave various degrees of long-term permanent disability. While several methods such as
pharmacologic therapy, microneurosurgery, autogenous and alloplastic grafting can be used for the
treatment of long-standing sensory aberrations in the inferior alveolar nerve, there are few reports
regarding low level laser treatment. This paper reports the effects of low level laser therapy in 4
patients with longstanding sensory nerve impairment following mandibular third molar surgery.
Methods: Four female patients had complaints of paresthesia and dysesthesia of the lip, chin and
gingiva, and buccal regions. Each patient had undergone mandibular third molar surgery at least 1
year before. All patients were treated with low level laser therapy. Clinical neurosensory tests (the
brush stroke directional discrimination test, 2-point discrimination test, and a subjective
assessment of neurosensory function using a visual analog scale) were used before and after
treatment, and the responses were plotted over time.
Results: When the neurosensory assessment scores after treatment with LLL therapy were
compared with the baseline values prior to treatment, there was a significant acceleration in the
time course, as well as in the magnitude, of neurosensory return. The VAS analysis revealed
progressive improvement over time.
Conclusion: Low level laser therapy seemed to be conducive to the reduction of long-standing
sensory nerve impairment following third molar surgery. Further studies are worthwhile regarding
the clinical application of this treatment modality.
Background
The close anatomic relationship between the inferior alve-
olar nerve (IAN) and the roots of an impacted mandibular
third molar tooth is well known. Therefore, the possibility
of injury to the IAN resulting in paresthesia in the course
of the surgical removal of the impacted mandibular third
molars has been widely demonstrated [1-5]. The inci-
dence of nerve damage after the removal of mandibular
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third molar teeth ranges from 0.4% to 8.4% [6-13]. In the
majority of cases, altered sensation is a transitory phe-
nomenon [1,15]. However, some persist for longer than 6
months, which can leave various degrees of long-term per-
manent disability.
Presently, there is no standardized protocol in the evalua-
tion and management of patients with IAN injury. There
are several methods which can be used for the treatment
of longstanding sensory aberrations in the IAN. A multi-
tude of surgical modalities are currently used in nerve
repair including epineural repair, perineural repair, autog-
enous interpositional nerve grafts, vein grafts, and entu-
bulation, with or without the use of neurotrophic and
neurotropic factors which apply to the IAN [6,16-20].
Some persistent nerve alterations may be due to scar tissue
entrapment of the nerve causing a conduction block or
preventing regeneration as a result of compression. This
generally requires an external or internal neurolysis
[6,15]. Anatomic and physiologic studies have confirmed
that injured nerve trunks might form neuromas [21]. In
the case of neuroma formation, the resection of the neu-
roma and debridement of the nerve segments is under-
taken until healthy neural fascicles are encountered [6].
When neural tissue is resected or has been previously
destroyed, a gap forms between proximal and distal nerve
stumps. Direct approximation of the nerve stumps would
result in harmful tension across the suture line. Either the
nerve should be mobilized, rerouted or a nerve graft inter-
posed to avoid longitudinal suture line tension [6,35]. If
primary anastomosis can not be achieved without ten-
sion, then a sural, greater auricular or medial ante-bra-
chial cutaneous nerve may be necessary to span a large
nerve defect. However, this requires a second surgical site
with increased morbidity at the graft harvest site
[6,36,37].
The long term results of surgical procedures which appear
to be varied and anecdotal, have been inconclusive in the
current and past literature [14,20]. Some studies state that
early nerve repair appears to provide better results than
does late repair [20,38,39]. However, this is not univer-
sally accepted. There are other reports in the literature
which state that timing has little effect on the success of
nerve repair procedures [40,41]. There is no consensus on
exactly what constitutes an early versus late repair,
because some have advocated that late repairs are those
performed after 1 year and others have stated that they are
repairs performed after 3 months [14]. Another critical
issue is performing the indicated surgery. It seems that
direct nerve anastomosis provides better results than a
graft. Meanwhile, the data from recent preliminary studies
also shows that the use of Gore-Tex tubes as grafts may be
unsuccessful [42,43]. Rutner et al [20] concluded that
trigeminal microsurgery is indicated in patients with a
peripheral neuropathic lesion and clinically accompanied
by hyperalgesia and hyperpathia. Patients with dysesthe-
sia had more neuroses and depression with long-standing
pain symptoms which have a poor prognosis with micro-
surgery.
It is apparent from the literature that the value of surgical
approaches to the IAN which have been described for the
management of IAN injury remain uncertain, and indeed
some procedures may do harm than good [16].
Besides these surgical modalities, low level laser (LLL)
therapy can also used for the treatment of nerve injuries.
There have been many claims for the therapeutic effects of
LLL treatment such as acceleration of wound healing [22],
pain attenuation [4,24,23], restoration of normal neural
function following injury [6,11,25,26], enhanced remod-
eling and repair of bone, normalization of abnormal hor-
monal function, stimulation of endorphin release and
modulation of the immune system. Published data on
efficacy exist for some but not all of these applications
[27]. There are several studies reported in the treatment of
IAN injury. These studies were reported by Midamda [28],
and Khullar et al. [11,44] in both subjective and objective
neurosensory impairment after LLL treatment of IAN par-
esthesia. Recently, Miloro et al reported the LLL effect
both on neural regeneration in surgically created defects
[6], and on neurosensory recovery after sagittal ramus
osteotomy [25]. They used gallium-aluminum-arsenide
(GaAlAs) LLL in patients with neurosensory impairment,
and they reported both subjective and objective improve-
ment in IAN after LLL treatment. Because LLL is relatively
noninvasive, its ability to stimulate injured nerves with-
out surgical intervention is desirable [36]. There have
been only a few studies recently reported in the literature
about the influence of LLL on neural regeneration espe-
cially IAN. Hence, it was considered worthwhile to see the
Table 1: The details of the patients with neurosensory deficit after third molar surgery
Patient Date of Surgery (mo,yr) Age at start of treatment (yrs) Time after injury before starting 
treatment (months)
I 11,2004 21 15
II 6,2003 24 21
III 5,2004 24 12
IV 1,2004 22 18Head & Face Medicine 2006, 2:3 http://www.head-face-med.com/content/2/1/3
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effects of low-level laser treatment with GaAlAs laser
resulting in objectively and subjectively verified improve-
ment in sensory perception after a long-standing post-sur-
gical inferior alveolar nerve injury, and to make a
contribution to the studies in the literature about this
treatment modality.
Methods
The subjects consisted of 4 female patients with an age
range of 21–24 years with post-surgical sensory abnor-
malities lasting longer than 1 year in the distribution of
the inferior alveolar nerve subsequent to surgical removal
of impacted mandibular third molar teeth (Table 1). Sur-
geons who were graduate dentists specializing in Oral Sur-
gery (in their second, or third year) performed all the
extractions employing a common surgical procedure. The
surgical field and all surgical materials were sterile. All
subjects received IAN block injections of 1.8 ml of 2%
lidocaine (36 mg) with 1:100,000 epinephrine (18 µg),
(Xylocaine, Dentsply Pharmaceutical, York, PA). The Infe-
rior alveolar nerve anesthetic technique was used (direct
truncal block) for the IAN block. Infiltrating anesthesia
was also performed in the vestibular region innervated by
the buccal nerve to ensure that the surgical fields were
fully anesthetized. Submucosal injection was also made in
the vestibular fundus of the region of the lower and third
molar using a standard 27-gauge 1 1/2 inch (Monoject,
Sherwood Medical, St. Louis, MO) needle attached to a
standard aspirating syringe. After the target area was
reached and aspiration performed, the anesthetic solution
was deposited over a 1 minute time period. A standard
incision was used from the anterior border of the ramus to
A montage of the panoramic radiographs of the four patients showing in each case the close spatial relationship between the  mandibular third molar teeth and the IAN Figure 1
A montage of the panoramic radiographs of the four patients showing in each case the close spatial relationship between the 
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the disto-facial corner of the second molar following the
buccal gingival sulcus along the second and first molars.
After periosteal elevation, the bone surrounding the third
molar was removed with a round bur in a handpiece using
a copious amount of saline irrigation. The third molars
were split using a tungsten fissure bur and a straight eleva-
tor as the routine technique. The tooth was then removed
in several pieces. The alveolus was inspected for granula-
tion tissue followed by copious irrigation with saline. Clo-
sure was accomplished with 3-0 silk sutures. A gauze pack
was pressed against the surgical site and the patient was
instructed to bite upon this for half an hour. Following
the surgery, the patient was given no medication other
than post-operative antibiotics and analgesics.
After the third molar surgeries, subsequent neurosensory
impairment had occurred in the patients. These impair-
ments were as follows: two patients had slightly painful
dysesthesia of lip, chin and gingival regions (patients II
and IV), while patient I had hypoesthesia on the area of
the chin, gingiva, buccal regions and the lips, and patient
III had complete paresthesia caused by the injury of the
IAN. Besides these impairments, the clinical examination
of the patients also revealed no alterations of sensation in
the tongue, no taste problems or thermal sensation prob-
lems. The pre-operative panoramic radiographs revealed
the close relationship between the right mandibular third
molar tooth and the IAN before surgery (Figure 1). It was
thought that these impairments had formed due to either
the third molar surgery or the local anesthetic injection
with or without direct needle trauma. No treatment, sur-
gical or otherwise, had been provided for the treatment of
these complaints after surgery. According to Tay [7], the
persistence of sensory alteration at 1 year suggests the
presence of Sunderland fourth-degree injury. It was indi-
cated in the surgical records of the patients that there were
no complete transections. Thus, using Sunderland's classi-
fication in accordance with several studies [6,45], these
patients were classified as at best third-degree with
intraneural fascicular disruption and/or scarring.
All patients were reviewed on the first postoperative day
and again 1 week after surgery. These patients were also
monitored after 15 days and 1, 3, 6 and 9 months for
recovery. After the 9-month follow-up, patients I and III
could not be reached until they referred back to our clinic.
The other patients (patients II and IV) were monitored at
the 1-year mark and also at 18 months. After 18 months,
the injury was considered to be permanent for these
patients. Overall, the mean of the follow-up period of the
patients was 13.5 months with a range of 9 to 18 months.
All examinations and treatments were performed with the
signed consent of the patient as well as the presence of a
witness. All four patients decided to undergo treatment
with LLL.
The study was conducted on a double blind basis. The
treatments took place over a time period of 39 days at 2
day intervals following the protocol of Khullar et al [11].
The LLL treatments and recording of data were performed
by a second doctor not involved in any of the surgeries,
and the analysis of the recorded data was performed by a
third doctor.
LLL treatment
A photon-plus GaAlAs diode laser LLL system (Laser Med-
ical Systems, ApS, Hedehusene, Denmark) was used. The
unit had a contact probe with a laser beam diameter of 0.5
cm. The system delivers a 70 mW output that emits a
wavelength of 820-to-830 nm. The irradiance used was
6.0 J per treatment site, which was delivered by applying
5 mW in continuous wave mode for approximately 90
seconds. Each patient received a total of 20 LLL treatment
sessions. The patients were treated at 2 day intervals, 3
times a week until all sessions were completed. The laser
probe was applied directly to the treatment sites. The
patients experienced no sensation when the laser treat-
ments were being carried out. A beeping noise was made
at the beginning and at the end the end of the treatment.
The treatment time per point was 90 seconds. Thus, one
treatment session, consisting of 5 treatment sites, took
approximately 8 minutes. The treatment sites were as fol-
lows: extraorally: the lower lip, chin and the region of
mental foramen (Figure 2); intraorally: the mental
foramen region, buccally in the region of the apicies of the
first molar, and lingually in the region of the mandibular
foramen (Figure 3).
The extra-oral LLL treatment points used Figure 2
The extra-oral LLL treatment points used.Head & Face Medicine 2006, 2:3 http://www.head-face-med.com/content/2/1/3
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Assessment of neurosensory deficit
To determine the degree of sensory nerve damage, both
objective and subjective measurements were made. All
patients underwent a complete pre- and post-treatment
clinical neurosensory test (CNT), as described previously
by Pogrel [14] and Miloro et al [25]. This consisted of
three parts: a brush stroke directional discrimination test
for fine touch and direction sense, a 2-point discrimina-
tion test, and subjective assessment of the neurosensory
deficit using a visual analog scale (VAS). All tests were per-
formed in a dark, quiet room, with the patient's eyes
closed. The neurosensory tests were explained to the
patient and performed on a control site (i.e., hand, or
arm) to confirm that the patient understood the test
before formal testing of the IAN. The brush stroke direc-
tional discrimination test was performed first. A fine No.2
sable brush that consistently evoked sensation in the
injured area was chosen. This was then used to map the
area of paresthesia, and the brush rubbed across the test
area in an anterior or posterior direction. The patient's
responses to identifying the direction of movement were
recorded as the number correct out of 10 tests. For the sec-
ond test, 2-point discrimination was performed by using
a Boley gauge with blunt points, which was intended to
elicit a non-painful response. The number of millimeters
of separation that could be discerned consistently was
used as the discrimination value for this test. Subjective
neurosensory assessment was performed by using a 10-
cm, 5-degree VAS with divisions at 2.5 cm intervals as
described previously by Miloro et al [25]. The divisions on
the VAS scale were as follows; 1- Complete absence of sen-
sation 2- Almost no sensation 3- Reduced sensation 4-
Almost normal sensation 5- Fully normal sensation.
Patients were asked to make an "x" on the line at each test-
ing session. The distances along the line were measured
and recorded. Although the study group was quite small,
the Wilcoxon statistical test was performed using the SPSS
11.0 package (SPSS Inc., Chicago, IL) for Windows (p
<0.05) for the evaluation of statistical significance.
Results
All patients fully cooperated as regards their treatment ses-
sions and all completed the treatment sessions. The
patients reported no side effects during or after the LLL
treatment. The average and standard deviations of the
patients before LLL treatment were; 1.75 (s.d. 0.5)
(number correct out of 10 tests for brush stroke direc-
tional discrimination test in Figure 4), 11.49 (s.d.0.73)
millimeters (for 2-point discrimination test in Figure 5).
After LLL treatment, it was constituted as; 8 for brush
stroke test, and 7.7 (s.d.0.16) for 2-point discrimination
test. Statistically, when subjective assessment was evalu-
ated, there was a significant improvement in the assess-
ment of the degree of neurosensory deficit (p = 0,02),
while there were also statistical significant improvement
in the brush stroke directional discrimination test for fine
touch and direction sense (p = 0.01). Although there is a
tendency toward improvement in the 2-point discrimina-
tion test, no statistical difference can be found between
the pre and post treatment values (P = 0.07).
In general, when the neurosensory assessment scores after
treatment with LLL therapy were compared with the base-
line values prior to treatment, there was progressive
improvement over time, signifying return of neurosensory
functions. In all patients the responses to identifying the
direction of movement were increased dramatically.
Before the LLL treatment, the patients average responses
(Figure 4). This was accompanied by a significant
improvement in the 2-point discrimination test in all
patients (Figure 5). Subjective assessment using the VAS
also showed an improvement over time (Figure 6). Thus,
in all patients, sensation alterations were changed in a
positive manner as assessed both subjectively and objec-
tively.
Discussion
Involvement of, and damage to, the inferior alveolar may
result from a variety of clinical circumstances. Maxillofa-
cial trauma or involvement by neoplastic growth can
cause sensory dysfunction, but many cases occur as a
result of dental treatment [15,46]. The most common
cause is dentoalveolar surgery, in particular, the removal
of mandibular third molars [5-7,13,14]. Other causes
include orthognatic surgery [21,25,44,47], surgery for the
management of pathologic lesions of the jaws (most com-
monly, cystic lesions) [48], root canal therapy [49,50],
The intra-oral LLL treatment points used Figure 3
The intra-oral LLL treatment points used.Head & Face Medicine 2006, 2:3 http://www.head-face-med.com/content/2/1/3
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implant treatment [35,51], and injection of a local anes-
thetic nerve block [33,52-55]. Although most cases of
nerve damage are transient and spontaneously resolve
uneventfully with minimal sequelae, some persist [7].
There is generally little improvement in sensation on the
injured side when assessed either by objective means or
subjectively by the patient 9 months after compression
injury and 12 months after nerve section [11,56].
Several classification systems have been proposed for
nerve injuries, the best known being those by Seddon [31]
and Sunderland [32]. Seddon classified nerve injuries into
four classes: neuropraxia-conduction block resulting from
mild trauma, without axonal damage; axonotmesis-more
severe injury, with preservation of nerve sheath; neurot-
mesis-most severe injury- with nerve severance and
anesthesia in the nerve distribution. The Sunderland clas-
sification expands the Seddon classification of neuro-
praxia, axonotmesis, and neurotmesis into fifth-degree
nerve injury in increasing order of severity [6,33]. In Sun-
derland's second-, third, and fourth degree injuries, the
afferent or efferent fibers are damaged, but the endoneu-
rium and perineurium remain intact. Fifth-degree injury
implies nerve transsection. In our cases, no surgical
attempt was performed for treatment; thus, it was impos-
sible to classify these patients precisely. However, in our
opinion the persistence of sensory alteration at 1 year sug-
gests that the patients in this study have at best a Sunder-
land third-degree injury, or in fact, are more close to
having a fourth-degree injury.
Possible mechanisms of nerve injury in patients who sus-
tain sensory deficits after third molar surgery with
observed, intact IAN bundles include compression injury
or crush injury. The process of nerve regeneration after
compression or less severe crush injuries usually requires
several weeks to 6 months. If there is no sensory recovery
during this time, permanent loss of continuity in the
nerve trunk should be expected [7]. Mandibular third
molars, which have been radiographically judged to be in
close proximity to the mandibular canal, have in several
studies been linked to an elevated risk for postoperative
complications such as nerve damage [1-4]. Besides this,
several studies have indicated that local anesthesia itself
can also cause IAN damage, although such situations are
quite rare [52-55]. In a retrospective study, Haas and Len-
non [57] reported the incidence as 1:785 000 injections
while in another study, the incidence is cited as between
1:67 000 and 1:200 000 [5]. Also, studies conclude that
IAN injury occurs more frequently in later years [[5,9,12],
and [58]]. Bataineh [13] figured out a statistical signifi-
cance between the experience of operator and IAN par-
esthesia.
In this study, the subjects were young female individuals
and pre-operative radiographs demonstrated the close
relationship between the mandibular canal and the third
molars. The operations were performed by inexperienced
graduate dentists specializing in Oral Surgery. In our opin-
ion, the possible mechanism for nerve injury in our case
series may have resulted from compression, stretching or
partial section of the nerve, caused by bone fragments or
iatrogenic damage to instrumentation. Other possible rea-
son could be local anesthesia, including mechanical dam-
age of the nerve shaft by a barbed needle, mechanical
compression caused by internal hemorrhage or forced
injection of the anesthetic solution, or chemical action of
the anesthetic or of contaminating substances.
According to several studies, females were at higher risk of
developing postoperative complications than men, and
mainly women and older persons have the most severe
discomfort after oral nerve damage [58,59]. In a recent
report by Pogrel and Thamby, more females than males
were affected with neuropathic pain [53]. Moreover, other
studies which were conducted both in humans and ani-
mals indicated that females seem to have more postoper-
ative neurosensory deficit disturbances (especially
bilateral sagittal split osteotomy in humans) [20,47,60-
64]. In our study, all patients who underwent LLL treat-
ment were females. This finding is consistent with the pre-
viously published studies. Thus, it can be stated that
females are less likely to undergo spontaneous recovery
following nerve injury than are male subjects.
Mean results for the brush stroke directional discrimination  test, with the vertical axis representing number of scores  correct out of 10 (0 = indicating the pretreatment, and the x- axis indicating the days during LLL treatment) Figure 4
Mean results for the brush stroke directional discrimination 
test, with the vertical axis representing number of scores 
correct out of 10 (0 = indicating the pretreatment, and the x-
axis indicating the days during LLL treatment).Head & Face Medicine 2006, 2:3 http://www.head-face-med.com/content/2/1/3
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LLL therapy has been shown to both reduce the produc-
tion of inflammatory mediators of the arachidonic acid
family from injured nerves, and to promote regeneration
following injury [27]. The therapeutic effects of LLL treat-
ment include: acceleration of wound healing [22], pain
attenuation [23,24,34], restoration of normal neural func-
tion following injury [6,11,25,26], enhanced remodeling
and repair of bone, normalization of abnormal hormonal
function, stimulation of endorphin release, and modula-
tion of the immune system [27]. Clinical studies of the
effects of LLL therapy on injured nerves have revealed an
increase in nerve function and improved capacity for mye-
lin production [6]. LLL treatment has been shown to be
effective for promoting axonal growth in injured nerves in
animal model [27,29,30]. The direct application of this
technique to dentistry has yielded positive results in pro-
moting the regeneration of IAN. Sensory aberrations fol-
lowing IAN injuries can have a significant impact on the
quality of life. For this reason, interest has focused on the
use of LLL therapy for the treatment of persistent IAN
injury. Extensive use of LLL therapy in the perioral region
after nerve trauma has been investigated by several
researchers [6,11,25,28,44]
In a previous blind clinical trial Khullar et al. [11] investi-
gated the effects of LLL treatment using a GaAlAs laser on
sensory perception in a 15 patient population after a long-
standing post surgical IAN injury. The average time after
injury before starting treatment was 33.4 months. Six
patients received real LLL treatment while the seven
received placebo laser treatment. The results demon-
strated an overall significant improvement in mechano-
sensory perception subsequent to laser treatment
compared with the placebo LLL treated group. The patient
in the real laser treated group showed a 44% improve-
ment after LLL treatment. The result of this study is sup-
ported by an animal study demonstrating the
regeneration of motor nerves. In this animal study, LLL
treatment enhanced the recovery in terms of both the
motor and sensory functions after a crush injury to the sci-
atic nerve [65]. Midamba and Haanaes [28] have also
reported subjective improvement in patients suffering suf-
fering from IAN injuries for more than 6 months. IAN or
lingual nerve paresthesias after LLL treatment. An average
subjective improvement was found (71.1%) after 20 LLL
GaAlAs treatments. A further double blind study by
Khullar et al [44] has reported the effect of LLL treatment
on neurosensory deficit subsequent to sagittal split ramus
osteotomy. They divided their study group into two
groups; one (eight subjects) group received real LLL treat-
ment, the other group received an equivalent placebo
treatment. Subsequent to the completion of the 20 treat-
ments, the real LLL treated group showed a subjective sig-
nificant improvement in both lip (p = 0.01) and chin (p =
0.02). In addition, this group showed a significant
decrease in the area of mechanoperception neurosensory
deficit (p = 0.01). No significant improvement was seen in
the placebo group. More recently, Miloro et al. reported a
positive LLL effect both on neural regeneration in surgi-
cally created defects [6], and on neurosensory recovery
after sagittal ramus osteotomy [25]. They found signifi-
cant improvement in neurosensory recovery after a bilat-
eral sagittal split osteotomy, and also noted that LLL
therapy may be a useful adjunct to promote neural wound
healing in surgically created defects. The results in their
study also showed that there was a significant improve-
ment at 14 days and almost normal values by 2 months in
level B testing, while the results of level A testing
approached normal values by 14 days and virtually 100%
recovery at 2 months. The results of our study are higher
than those in previous studies, which do not show a 100%
improvement in patients with trigeminal injuries than
one year. In our opinion, this result may be due to a bias
in this study. Although it appeared subjectively that all the
patients were honest in their responses, the doctor who
performed the tests may have had some influence on the
answers. Certainly, there is significant correlation of sub-
jective outcomes. Also in this study, there is an interesting
finding: The patient with the oldest IAN injury (21
months) responded the most rapidly of all the patients.
Brugnera et al. [66] treated two groups of patients with
lesions to the inferior alveolar and mental nerves with LLL
in their study. All cases of paresthesia were due to surgical
interventions. The first group was identified as immediate
and was treated within 2–15 days after the injury, while
the history of injury for the second group was 30–365
days. In the first group 72.7% achieved absolute recovery
and 18.3% showed relative improvement, whereas the
improvement for the latter group was only 27.7%. In con-
trast to this report, patient II in our study made the most
significant improvement in comparison to others. This
finding may be consistent with a hypothesis that follow-
Mean results for the 2-point discrimination test, with the  data expressed in millimeters Figure 5
Mean results for the 2-point discrimination test, with the 
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ing damage to the nerves, the afferent and special sensory
fibers have different patterns of wound healing and
axonal regeneration, and that these patterns vary from
person to person [61]. However, in our opinion, further
studies must be conducted on this issue in order to clarify
this finding.
Conclusion
The results of the current study support the findings of the
previous ones which concluded that LLL treatment results
in both subjective and objective improvement in long-
standing neurosensory deficit. Although several studies
state that microsurgical repair of the nerve injuries can
provide moderate to significant clinical neurosensory
improvement after surgery, LLL therapy appears to be
more beneficial and advantageous as it is non-invasive
when reducing longstanding sensory nerve impairment
following third molar surgery.
There is an urgent need for more studies to be undertaken
and for the results of these to be disseminated widely to
clinicians using LLL treatment. Only then will the aura of
controversy and the stigma be removed from this area of
clinical practice [27].
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